BuShenKangShuai Tablet Alleviates Hepatic Steatosis via Improving Liver Adiponectin Resistance in ApoE^-/- Mice

Figure 1

Effect of BuShenKangShuai tablet (BSKS) on the hepatic steatosis in ApoE−/− mice. Representative photomicrographs of Hematoxylin and Eosin staining of liver. The area of liver tissue was measured by Image-Pro Plus 6.0 (magnification, ×400). (a) No significant hepatic steatosis could be found in control group. (b) Hepatocyte nuclear ballooning, hepatocyte apoptosis, Mallory’s hyaline, and inflammation foci were the main types of hepatic histopathological changes in model group. (c) The above histopathological changes were significantly improved in BSKS group. (d) Atorvastatin could also significantly alleviate the above histopathological changes. Except for this, the hepatic cells were arranged more closely in atorvastatin group. Scale bars 50 μm.

(a)

(b)

(c)

(d)